Compare HROW & GABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HROW | GABC |
|---|---|---|
| Founded | 1998 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | N/A | N/A |
| Metric | HROW | GABC |
|---|---|---|
| Price | $50.54 | $40.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | ★ $68.86 | $45.50 |
| AVG Volume (30 Days) | ★ 616.6K | 142.4K |
| Earning Date | 11-10-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 2.86% |
| EPS Growth | N/A | ★ 3.79 |
| EPS | N/A | ★ 2.87 |
| Revenue | $250,042,000.00 | ★ $312,775,000.00 |
| Revenue This Year | $38.96 | $47.67 |
| Revenue Next Year | $43.38 | $6.23 |
| P/E Ratio | ★ N/A | $14.13 |
| Revenue Growth | ★ 47.83 | 26.55 |
| 52 Week Low | $20.85 | $32.75 |
| 52 Week High | $54.85 | $43.20 |
| Indicator | HROW | GABC |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 55.75 |
| Support Level | $46.58 | $38.55 |
| Resistance Level | $54.85 | $40.14 |
| Average True Range (ATR) | 2.51 | 0.76 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 58.95 | 64.84 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.